Innovent Biologics (1801N) Earnings Dates, Call Summary & Reports

The P/E ratio of {name} is N/A.

1 Followers

Earnings Data

Report Date

Mar 31, 2027

TBA (Confirmed)

Period Ending

2026 (Q4)

Consensus EPS Forecast

3.05

Last Year’s EPS

-0.03

Same Quarter Last Year

Strong Buy

Based on 22 Analysts Ratings

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

MX:1801N Upcoming Earnings

Innovent Biologics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Mar 31, 2027	2026 (Q4)	3.05 / -	-0.027	―	―	―
Aug 25, 2026	2026 (Q2)	1.26 / 1.88	1.366	37.25% (+0.51)		―
Mar 26, 2026	2025 (Q4)	0.32 / -0.03	0.482	-105.56% (-0.51)		―
Aug 27, 2025	2025 (Q2)	0.48 / 1.37	-0.643	312.50% (+2.01)		―
Mar 26, 2025	2024 (Q4)	-0.62 / 0.48	-1.522	131.69% (+2.00)		―
Aug 28, 2024	2024 (Q2)	-0.67 / -0.64	-0.241	-166.67% (-0.40)		―
Mar 20, 2024	2023 (Q4)	-1.88 / -1.52	-2.251	32.38% (+0.73)		―
Aug 23, 2023	2023 (Q2)	-1.80 / -0.24	-1.742	86.15% (+1.50)	―	―
Mar 31, 2023	2022 (Q4)	-1.77 / -2.25	-3.617	37.78% (+1.37)	―	―
Aug 25, 2022	2022 (Q2)	-18.34 / -1.74	-2.17	19.75% (+0.43)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

When does Innovent Biologics (MX:1801N) report earnings?

Innovent Biologics (MX:1801N) is schdueled to report earning on Mar 31, 2027, TBA (Confirmed).

What is Innovent Biologics (MX:1801N) earnings time?

Innovent Biologics (MX:1801N) earnings time is at Mar 31, 2027, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Innovent Biologics stock?

The P/E ratio of Innovent Biologics is N/A.

What is MX:1801N EPS forecast?

MX:1801N EPS forecast for the fiscal quarter 2026 (Q4) is 3.05.